[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TR200100448T2 - Fenil ksantin türevleri - Google Patents

Fenil ksantin türevleri

Info

Publication number
TR200100448T2
TR200100448T2 TR2001/00448T TR200100448T TR200100448T2 TR 200100448 T2 TR200100448 T2 TR 200100448T2 TR 2001/00448 T TR2001/00448 T TR 2001/00448T TR 200100448 T TR200100448 T TR 200100448T TR 200100448 T2 TR200100448 T2 TR 200100448T2
Authority
TR
Turkey
Prior art keywords
xanthine derivatives
disorders
phenyl
phenyl xanthine
compounds
Prior art date
Application number
TR2001/00448T
Other languages
English (en)
Inventor
Mary Daluge Susan
Holder Jurgensen Cynthia
Tolar Martin Michael
Howard Osterhout Martin
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR200100448T2 publication Critical patent/TR200100448T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Bu bulus, (I) formülünün yeni bilesiklerine; bu bilesiklerin hazirlanmasi için islemlere; bunlari ihtiva eden farmasötik formülasyonlara ve bunlarin tipta, özellikle, iltilaplanma kosullari, bagisiklik bozukluklari, septik sok, dolasim bozukluklari ve gastrointestinal iltihaplanmalar ve bozukluklarin tedavisi ve profilaksinda kullanimlarina iliskindir.
TR2001/00448T 1998-08-13 1999-08-11 Fenil ksantin türevleri TR200100448T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9817623.3A GB9817623D0 (en) 1998-08-13 1998-08-13 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
TR200100448T2 true TR200100448T2 (tr) 2001-09-21

Family

ID=10837179

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00448T TR200100448T2 (tr) 1998-08-13 1999-08-11 Fenil ksantin türevleri

Country Status (36)

Country Link
US (3) US6608069B1 (tr)
EP (1) EP1104422B1 (tr)
JP (3) JP3631961B2 (tr)
KR (1) KR20010085369A (tr)
CN (2) CN1149215C (tr)
AP (1) AP1408A (tr)
AR (1) AR020154A1 (tr)
AT (1) ATE259810T1 (tr)
AU (1) AU775819B2 (tr)
BR (1) BR9913020A (tr)
CA (1) CA2340350A1 (tr)
CO (1) CO5130007A1 (tr)
DE (1) DE69914921T2 (tr)
DK (1) DK1104422T3 (tr)
EA (1) EA004139B1 (tr)
EE (1) EE04721B1 (tr)
ES (1) ES2215399T3 (tr)
GB (1) GB9817623D0 (tr)
HU (1) HUP0103637A3 (tr)
ID (1) ID28723A (tr)
IL (1) IL141318A0 (tr)
IS (1) IS5843A (tr)
MA (1) MA26673A1 (tr)
MY (1) MY133393A (tr)
NO (1) NO20010715L (tr)
NZ (1) NZ509778A (tr)
PE (1) PE20000952A1 (tr)
PL (1) PL346055A1 (tr)
PT (1) PT1104422E (tr)
SI (1) SI1104422T1 (tr)
SK (1) SK2222001A3 (tr)
TR (1) TR200100448T2 (tr)
TW (1) TWI224598B (tr)
WO (1) WO2000009507A1 (tr)
YU (1) YU11601A (tr)
ZA (1) ZA200101186B (tr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
CA2428753C (en) * 2000-11-17 2013-05-21 Idenix (Cayman) Limited Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines
DE60211495T2 (de) * 2001-02-28 2006-12-14 Smithkline Beecham Corp. Xanthin-glycol-derivate zur behandlung des reizdarmsyndroms
EP1418882A1 (en) 2001-08-24 2004-05-19 Unilever N.V. Oral composition comprising an alkylhydroxybenzoate
US7125993B2 (en) 2001-11-09 2006-10-24 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
KR100937620B1 (ko) 2001-11-09 2010-01-20 씨브이 쎄러퓨틱스, 인코포레이티드 Ａ２ｂ 아데노신 수용체 길항제
US7317017B2 (en) 2002-11-08 2008-01-08 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US6977300B2 (en) 2001-11-09 2005-12-20 Cv Therapeutics, Inc. A2B adenosine receptor antagonists
US20040072848A1 (en) * 2002-02-26 2004-04-15 Huber Brian E Methods of treating irritable bowel syndrome and functional dyspepsia
AU2003231805A1 (en) 2002-06-17 2004-02-09 Glaxo Group Limited Purine derivatives as liver x receptor agonists
NZ545715A (en) * 2003-08-25 2009-02-28 Adenosine Therapeutics Llc Substituted 8-heteroaryl xanthines
GB0324086D0 (en) * 2003-10-14 2003-11-19 Glaxo Group Ltd Process for preparing a co-precipitate of a non-crystalline solid drug substance
US20060063828A1 (en) * 2004-06-28 2006-03-23 Weingarten M D 1,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
US7598379B2 (en) * 2005-02-25 2009-10-06 Pgx Health, Llc Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
WO2006091898A2 (en) * 2005-02-25 2006-08-31 Adenosine Therapeutics, Llc Pyrazolyl substituted xanthines
US7884100B2 (en) * 2006-06-16 2011-02-08 Pgxhealth, Llc Substituted 8-[6-amino-3-pyridyl]xanthines
WO2009140519A1 (en) * 2008-05-14 2009-11-19 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries
WO2009140517A1 (en) 2008-05-14 2009-11-19 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries
US8318728B2 (en) 2008-05-14 2012-11-27 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries
US8158624B2 (en) * 2008-05-30 2012-04-17 Genetech, Inc. Purine PI3K inhibitor compounds and methods of use
CN102260260B (zh) * 2010-05-24 2014-08-06 中国科学院上海药物研究所 8-苯基黄嘌呤类化合物、其制备方法、包含该化合物的药物组合物及其用途
CN102993203B (zh) * 2011-09-09 2015-11-25 温州医学院 8-苯基黄嘌呤类衍生物的制备及应用
US9502952B2 (en) 2012-10-12 2016-11-22 Persimmon Technologies, Corp. Hybrid motor
HK1221662A1 (zh) 2013-05-10 2017-06-09 Gilead Apollo, Llc Acc抑制劑和其用途
EA030958B1 (ru) 2013-05-10 2018-10-31 Джилид Аполло, Ллс Ингибиторы акк и их применение
CA2911932A1 (en) 2013-05-10 2014-11-13 Nimbus Apollo, Inc. Acc inhibitors and uses thereof
HK1221659A1 (zh) * 2013-05-10 2017-06-09 Gilead Apollo, Llc Acc抑制劑和其用途
AU2023413736A1 (en) 2022-12-20 2025-06-26 Invios Gmbh Substituted 3,7-dihydro-1 h-purine-2,6-diones and use thereof
EP4389749A1 (en) * 2022-12-20 2024-06-26 invIOs GmbH Substituted 3,7-dihydro-1h-purine-2,6-diones and use thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442125A (en) * 1978-06-26 1984-04-10 Oxford Hill, Ltd. Process for detaching or preventing attachment of microorganisms to a surface
GB8510758D0 (en) 1985-04-27 1985-06-05 Wellcome Found Compounds
US4968672A (en) * 1987-01-02 1990-11-06 The United States Of America As Represented By The Department Of Health And Human Services Adenosine receptor prodrugs
US5015647A (en) 1987-04-24 1991-05-14 Burroughs Wellcome Co. Method for treating viral infections
GB8826595D0 (en) 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
NZ240644A (en) 1990-11-21 1994-08-26 Smithkline Beecham Corp Use of xanthine derivatives to inhibit the production of tumour necrosis factor (tnf)
GB9210839D0 (en) 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
TW252044B (tr) 1992-08-10 1995-07-21 Boehringer Ingelheim Kg
JP2613355B2 (ja) 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
WO1995013094A1 (en) * 1993-11-10 1995-05-18 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
US5395831A (en) 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
GB9415529D0 (en) * 1994-08-01 1994-09-21 Wellcome Found Phenyl xanthine derivatives
DE19535504A1 (de) 1995-09-25 1997-03-27 Bayer Ag Substituierte Xanthine
WO1997034616A1 (en) 1996-03-18 1997-09-25 Medical Science Systems, Inc. A method for periodontal disease treatment
SI0812844T1 (en) 1996-06-07 2003-02-28 Hoechst Aktiengesellschaft Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
US6096707A (en) * 1997-07-11 2000-08-01 Biotie Therapies Ltd. Integrin binding peptide and use thereof
US6117878A (en) * 1998-02-24 2000-09-12 University Of Virginia 8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
AU2640999A (en) 1998-02-26 1999-09-15 Zenyaku Kogyo Kabushiki Kaisha 1-azaindolizine derivatives
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
BR0017037A (pt) 1999-12-23 2003-06-10 Nitromed Inc Inibidores de ciclooxigenase-2 nitrosados e nitrosilados, composições e métodos de uso
US20020006915A1 (en) * 2000-02-15 2002-01-17 Mack Strong Vivian E. Use of COX-2 inhibitors to treat sepsis, complications thereof, and EP receptor modulation
US6751206B1 (en) 2000-06-29 2004-06-15 Qualcomm Incorporated Method and apparatus for beam switching in a wireless communication system

Also Published As

Publication number Publication date
ZA200101186B (en) 2002-02-12
NZ509778A (en) 2003-08-29
AR020154A1 (es) 2002-04-10
EP1104422A1 (en) 2001-06-06
NO20010715D0 (no) 2001-02-12
CN1251676C (zh) 2006-04-19
JP2002522542A (ja) 2002-07-23
HK1035195A1 (en) 2001-11-16
BR9913020A (pt) 2001-05-08
KR20010085369A (ko) 2001-09-07
CO5130007A1 (es) 2002-02-27
PL346055A1 (en) 2002-01-14
PT1104422E (pt) 2004-06-30
ID28723A (id) 2001-06-28
HUP0103637A3 (en) 2002-10-28
US20030032804A1 (en) 2003-02-13
US6770267B2 (en) 2004-08-03
EP1104422B1 (en) 2004-02-18
EA200100127A1 (ru) 2001-10-22
MY133393A (en) 2007-11-30
PE20000952A1 (es) 2000-09-29
GB9817623D0 (en) 1998-10-07
US6608069B1 (en) 2003-08-19
AP1408A (en) 2005-05-06
DE69914921D1 (en) 2004-03-25
CN1515571A (zh) 2004-07-28
IS5843A (is) 2001-02-09
SI1104422T1 (en) 2004-06-30
CN1149215C (zh) 2004-05-12
SK2222001A3 (en) 2001-12-03
AU5732399A (en) 2000-03-06
HUP0103637A2 (en) 2002-06-29
US20040034020A1 (en) 2004-02-19
EE200100083A (et) 2002-06-17
DE69914921T2 (de) 2004-12-23
ES2215399T3 (es) 2004-10-01
YU11601A (sh) 2004-03-12
EE04721B1 (et) 2006-10-16
WO2000009507A1 (en) 2000-02-24
AU775819B2 (en) 2004-08-19
ATE259810T1 (de) 2004-03-15
JP2004115534A (ja) 2004-04-15
JP3631961B2 (ja) 2005-03-23
TWI224598B (en) 2004-12-01
CN1323309A (zh) 2001-11-21
IL141318A0 (en) 2002-03-10
NO20010715L (no) 2001-04-02
CA2340350A1 (en) 2000-02-24
DK1104422T3 (da) 2004-06-14
MA26673A1 (fr) 2004-12-20
AP2001002071A0 (en) 2001-03-31
JP2004137251A (ja) 2004-05-13
EA004139B1 (ru) 2004-02-26

Similar Documents

Publication Publication Date Title
TR200100448T2 (tr) Fenil ksantin türevleri
TR200101709T2 (tr) İltihabik hastalıkların tedavisinde yararlı olan bileşikler
TR199901905T2 (tr) 2-(Pürin-9-il)-tetrahidrofuran-3,4-diol türevleri.
TR200100410T2 (tr) 2-(purin-9-il)-tetrahidrofuran-3,4-diol türevleri.
TR200102817T2 (tr) Antiinflamatuar ajanlar olarak faydalı bileşikler
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
YU39101A (sh) Aromatična hetrerociklična jedinjenja kao antiinflamatorni agensi
ATE309237T1 (de) Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
DE69912606D1 (de) 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivate
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
DE69920757D1 (de) Immunsuppressive wirkungen von pteridinderivaten
TR200000481T2 (tr) N-Alkonoilfenilalenin türevleri.
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
TR200200068T2 (tr) Nematisital triflüorobütenler
TR200100411T2 (tr) 2-(Pürin-9-il)-tetrahidrofuran-3,4-diol türevleri.
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
WO2004106293A3 (en) Oxazolyl - and thiazolyl - purine based tricyclic compounds.
TNSN01012A1 (fr) Derives amines de dihydro-1, 3,5-triazine et leurs applications en therapeutique
NO944946L (no) Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem
DE60310767D1 (de) PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
TR200101978T2 (tr) 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri.
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
EA200000741A1 (ru) Новые производные дигидроксигексановой кислоты
SE9802793D0 (sv) New compounds